Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  American journal of hospital pharmacy

• Publication date

  1977-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/AJHP/34.9.939PMID 20779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Strategies for Assessing Physical Compatibility of Calcium Folinate with Bicarbonate During Methotrexate Rescue Therapy in Pediatric Patients with Acute Lymphoblastic Leukemia

  2025cites this paper
• Physicochemical compatibility of alprostadil injection with parenteral medications used in neonatal intensive care settings

  2025cites this paper
• Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration

  2025cites this paper
• Comparative evaluation of amiodarone and furosemide compatibility under different mixing conditions

  2025cites this paper
• Investigation of incompatibilities of the parenteral drugs etacrynic acid and theophylline with other commonly used intravenous drugs in a paediatric cardiological intensive care unit

  2024cites this paper
• The Physicochemical Compatibility of Sildenafil Injection with Parenteral Medications Used in Neonatal Intensive Care Settings

  2024cites this paper
• Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings

  2024cites this paper
• Co-administration of Intravenous Drugs: Rapidly Troubleshooting the Solid Form Composition of a Precipitate in a Multi-drug Mixture Using On-Site Raman Spectroscopy

  2023cites this paper
• Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.

  2023cites this paper
• Physicochemical compatibility of pentoxifylline injection with high‐concentration parenteral medications

  2023cites this paper
• Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs.

  2022cites this paper
• Y‐site administration of electrolyte solutions and injectable acetaminophen—A physical compatibility study with combinations frequently used in pediatric intensive care and anesthesia

  2022cites this paper
• Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration

  2022cites this paper
• Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.

  2021cites this paper
• Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.

  2021cites this paper
• ad-Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration

  2021cites this paper
• ad-Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration

  2021cites this paper
• Supporting the use of sildenafil infusions in paediatric and neonatal intensive care - a compatibility study.

  2020cites this paper
• Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection

  2020cites this paper
• Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach

  2020cites this paper
• European Databases on Stability and Compatibility of Injectable Medicinal Products in Europe

  2020cites this paper
• Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units

  2020cites this paper
• Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.

  2020cites this paper
• The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures

  2019cites this paper
• Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine

  2019cites this paper
• Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs

  2019cites this paper
• In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.

  2019cites this paper
• Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration

  2019cites this paper
• European Databases on Stability and Compatibility of Injectable Medicinal Products in Europe

  2019cites this paper
• Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.

  2019cites this paper
• SP1 Medicines optimisation for paediatric patients with learning disability

  2018cites this paper
• Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy

  2018cites this paper
• Terminal Withdrawal of Mechanical Ventilation: A Hospice Perspective for the Intensivist

  2018cites this paper
• Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.

  2018cites this paper
• Physicochemical Compatibility of Amiodarone with Parenteral Nutrition

  2018cites this paper
• PHARMACEUTICAL INCOMPATIBILITES: A REVIEW

  2018cites this paper
• Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.

  2018cites this paper
• Physical compatibility of total parenteral nutrition and drugs in Y‐site administration to children from neonates to adolescents

  2017cites this paper
• Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.

  2017cites this paper
• Y-site Incompatibility between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?

  2017cites this paper
• Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.

  2017influential citation
• Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water

  2017cites this paper
• Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.

  2017cites this paper
• Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.

  2017cites this paper
• A Review of Agents for Palliative Sedation/Continuous Deep Sedation: Pharmacology and Practical Applications

  2017cites this paper
• Physikochemische Kompatibilität und Emulsionsstabilität von Propofol in Kombination mit häufig applizierten Analgetika und Sedativa

  2016cites this paper
• Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.

  2016cites this paper
• Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit

  2016cites this paper
• Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.

  2016cites this paper
• Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam

  2015cites this paper
• Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.

  2015cites this paper
• Compatibilité physique de médicaments administrés dans l’unité de soins intensifs

  2015cites this paper
• Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs during Simulated Y-Site Administration

  2015cites this paper
• Mapping of incompatibility assay: Bringing method to problem in critical care

  2014cites this paper
• Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide

  2014cites this paper
• Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine

  2014cites this paper
• A Novel Thyroid Hormone Mediated Regulation of HSV-1 Gene Expression and Replication is Specific to Neuronal Cells and Associated with Disruption of Chromatin Condensation.

  2014cites this paper
• CRITICAL CARE THERAPEUTICS

  2013cites this paper
• Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.

  2013cites this paper
• Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.

  2013cites this paper
• Physiochemical Stability of Intravenous Fat Emulsion in Combination with Medications Used for Resuscitation

  2013cites this paper
• Y-site Compatibility of Intravenous Drugs With Parenteral Nutrition.

  2013cites this paper
• In vitro compatibility of various cardioactive drugs during simulated Y-site administration

  2013cites this paper
• In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs

  2012cites this paper
• Administration des médicaments par voie intraveineuse aux soins intensifs adultes : évaluation et validation des pratiques par la littérature et des essais en laboratoire

  2012cites this paper
• Comparison between original and generic versions of ceftriaxone sodium preparation for injection: compatibility with calcium-containing product.

  2012cites this paper
• Visual compatibility of micafungin sodium and levofloxacin injections.

  2012cites this paper
• A 5% glucose infusion fluid provokes significant precipitation of phenytoin sodium injection via interruption of the cosolvent effect of propylene glycol.

  2012cites this paper
• Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.

  2011cites this paper
• [Physical compatibility of sodium bicarbonate with other drugs often administered in the intensive care unit].

  2011cites this paper
• Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos

  2011cites this paper
• Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.

  2011cites this paper
• Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad

  2011cites this paper
• [Physical compatibility of furosemide in intravenous mixtures for continuous perfusion].

  2010cites this paper
• Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units

  2010cites this paper
• Visual compatibility of oritavancin diphosphate with selected coadministered drugs during simulated Y-site administration.

  2010cites this paper
• Prediction of incompatibility of ceftriaxone sodium with calcium ions using the ionic product.

  2010cites this paper
• Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua

  2010cites this paper
• Technology Update: IV Drugs

  2009cites this paper
• Evaluation of intravenous drug compatibilities in an adult intensive care unit

  2009cites this paper
• Drug incompatibility chemistry.

  2009cites this paper
• The effect of nimodipine, fentanyl and remifentanil intravenous products on the stability of propofol emulsions.

  2009cites this paper
• Compatibility and stability of palonosetron hydrochloride and propofol during simulated y-site administration.

  2009cites this paper
• Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection.

  2008cites this paper
• Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration.

  2008cites this paper
• Standardization of infusion solutions to reduce the risk of incompatibility.

  2008cites this paper
• Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.

  2008cites this paper
• Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.

  2008cites this paper
• Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated y-site administration.

  2008cites this paper
• Compatibility of doripenem with other drugs during simulated Y-site administration.

  2008cites this paper
• Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated y-site administration.

  2008cites this paper
• Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration

  2008cites this paper
• Compatibility and stability of palonosetron hydrochloride with four neruomuscular blocking agents during simulated y-site administration.

  2008cites this paper
• Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during simulated Y-site administration.

  2007cites this paper
• Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration

  2007cites this paper
• Visual compatibility of furosemide with phenylephrine and vasopressin.

  2006cites this paper
• Compatibility of micafungin injection with other drugs during simulated y-site co-administration.

  2006cites this paper
• Compatibility of anidulafungin with other drugs during simulated Y-site administration.

  2005cites this paper
• Visual compatibility of atosiban acetate with four drugs.

  2005cites this paper
• Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration.

  2005cites this paper